
GC75317
Niraxostat
Also known as 1-[3-cyano-4-(2,2-dimethylpropoxy)phenyl]pyrazole-4-carboxylic acid
Niraxostat (Y-700; Piraxostat) is an orally active xanthine oxidoreductase (XOR) inhibitor used in the study of hyperuricemia and other diseases in which XOR may be involved
ChemicalCAS206884-98-2MW299.32FormulaC16H17N3O3
- CAS number
- 206884-98-2
- Molecular weight
- 299.32
- Formula
- C16H17N3O3
- Solubility
- DMSO: 83·33 mg/mL (278·40 mM; Need ultrasonic)
- InChIKey
- AETHRPHBGJAIBT-UHFFFAOYSA-N
- Catalogue number
- GC75317
- Brand
- GLPBIO
Computed properties PubChem CID 449035 · XLogP 2.8 · TPSA 88.1 Ų · H-bond donors 1
- XLogP
- 2.8
- TPSA
- 88.1 Ų
- H-bond donors
- 1
- H-bond acceptors
- 5
- Rotatable bonds
- 5
- Heavy atoms
- 22
SMILES CC(C)(C)COC1=C(C=C(C=C1)N2C=C(C=N2)C(=O)O)C#N
Computed descriptors from PubChem (CID 449035), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il